Home » Topics » Disease categories and therapies » Respiratory

Respiratory
RSS

CFC-free Intal comparable to CFC Intal

Feb. 25, 1997

Montelukast effective for chronic asthma

Feb. 25, 1997

Effects of montelukast on exercise-induced bronchoconstriction in children

Feb. 25, 1997

Intravenous pranlukast for mild to moderate asthma

Feb. 25, 1997

Safety and efficacy of pranlukast in asthma

Feb. 25, 1997

Oral pranlukast and cold air-induced bronchoconstriction

Feb. 25, 1997

Pranlukast for allergic rhinitis

Feb. 25, 1997

Imiquimod for postviral asthma-like syndrome

Feb. 25, 1997

Antiallergic effects of new PDE IV inhibitor described

Feb. 25, 1997

Efficacy of hydoxychloroquine in asthma

Feb. 24, 1997

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 24, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 24, 2025.
Researchers discover how glioblastoma tumors dodge chemotherapy
BioWorld MedTech
Researchers at the University of Sydney have uncovered a mechanism that may explain why glioblastoma returns after treatment, and the world-first discovery offers...
HIV research is close to a cure but far from ending the pandemic
BioWorld
Advances in antiretroviral therapy (ART) now allow people living with HIV to lead normal lives with undetectable and nontransmissible levels of the virus in their...
Apollo’s APL-4098 shows potent antileukemic effects
BioWorld Science
Apollo Therapeutics Ltd. has developed APL-4098, a small-molecule general control nonderepressible 2 (GCN2) inhibitor for the potential treatment of AML.